StonvexLoading…
StonvexStonvexStonvexCore line items from CYDY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2023 2023-05-31 | Annual 2022 2022-05-31 | Q1 2022 2022-02-28 | Q4 2021 2021-11-30 |
|---|---|---|---|---|
Revenue | $0.00 | $266.00K | $266.00K | $266.00K |
Operating Income | $-40.58M | $-145.40M | $-66.36M | $-46.96M |
Net Income | $-79.82M | $-210.82M | $-126.70M | $-40.08M |
EPS (Diluted) | $-0.10 | $-0.31 | $-0.19 | $-0.13 |
Total Assets | $11.29M | $29.18M | $94.08M | $103.70M |
Total Liabilities | $120.79M | $123.58M | $116.54M | $116.39M |
Cash & Equivalents | $2.54M | $4.23M | $1.36M | $8.88M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-71.71M | $-60.65M |
Shares Outstanding | 918.61M | 719.59M | 713.29M | 685.42M |